Expands the definition of opiates under GS 90-89 (listing Schedule I controlled substances) to include 39 additional chemical designations. Amends GS 90-89(1a) to change the alternative names for certain fentanyl derivatives. Amends GS 90-89 to enact new subdivision GS 90-89(1b) to include Nitazene derivatives as a Schedule I controlled substance including any of the specified derivatives, their salts, isomers, or salts of isomers unless specifically utilized as part of the manufacturing process by a commercial industry of a substance or material not intended for human ingestion or consumption, as a prescription administered under medical supervision, or for research at a recognized institution, whenever the existence of these salts, isomers, or salts of isomers is possible within the specific chemical designation or unless specifically excepted or listed in this or another schedule, structurally derived from benzimidazole by substitution at the 1-position nitrogen with an ethylamine group, and by substitution at the 2-position carbon with a benzyl group, whether or not the compound is further modified in any of specified ways. 

Modifies the listed chemical designation for the hallucinogenic substance at GS 90-89(3)mm so it now reads “5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT)" (was, same formula but no isopropyltryptamine, just propyltryptamine).  

Adds bromazolam to systemic depressants listed at GS 90-89(4). 

Adds cycloalkyl to the list of substituted cathinones considered stimulants under GS 90-89(5).  

Amends GS 90-89(7) (synthetic cannabinoids) to conform to statutory list. Modifies the statutory list of indole carboxamides (GS 90-89(7)(l)) so that it includes the described compounds substituted in one or both of the listed ways (was, just one of the listed ways). Modifies descriptions of listed substitution at the nitrogen of the carboxamide and adds reference to MDMB-ICA as a substance included in the definition.

Amends GS 90-89(7)(n), indazole carboxaldehydes, to add four additional groups. Modifies GS 90-89(7)(o) to so that it includes the described structurally derived compounds substituted in one or both of the listed ways (was, just one of the listed ways). Modifies descriptions of listed substitution at the nitrogen of the carboxamide deletes APINCACA as a substance and adds four more substances in the class. Adds four more substances (oxindoles, indole acetamides, indazole acetaldehydes, and pyrazoles) to the list of synthetic cannabinoids, as described.

Amends GS 90-90(2)h1 (pertaining to Schedule II controlled substances that are opioids/opiates) to read as follows: fentanyl immediate precursor chemical 4-anilino-N-phenethylpiperdine (ANPP) [(was, Fentanyl immediate precursor chemical, 4-anilino-N-phenethyl-4-piperidine (ANPP)]. Amends GS 90-91(k)11 (Schedule III controlled substances that are anabolic steroids) to change listing to Dehydrochloromethyltestosterone (was, Dehydrochlormethyltestosterone) and GS 90-91(k)16 to Mesterolone (was, Mesterolene).